Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: Atopic dermatitis, psoriasis and skin mastocytosis

Postepy Dermatologii i Alergologii

Volumn 31, Issue 2, 2014, Pages 84-91

  Nedoszytko, Bogusław ^a   Sokołowska Wojdyło, Małgorzata ^a   Ruckemann Dziurdzińska, Katarzyna ^a   Roszkiewicz, Jadwiga ^a   Nowicki, Roman J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Atopic dermatitis; Chemokine; Cytokines; Mastocytosis; Psoriasis

Indexed keywords

CHEMOKINE; CYTOKINE;

ATOPIC DERMATITIS; CELL HOMING; CELL INFILTRATION; CELL MIGRATION; DENDRITIC CELL; DERMATITIS; EOSINOPHIL; FIBROBLAST; HUMAN; KERATINOCYTE; LYMPHOCYTE; MAST CELL; MASTOCYTOSIS; MELANOCYTE; PATHOGENESIS; PSORIASIS; REVIEW; URTICARIA PIGMENTOSA;

EID: 84900327270     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2014.40920     Document Type: Review

References (45)

1. Goła̧b J, Jakóbisiak M, Lasek W. Immunology. PWN Warsaw 2002.
2. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111 (2 Suppl): S460-75.
3. Baggiolini M. Chemokines in pathology and medicine. J Int Med 2001; 250: 91-104. (Pubitemid 32868689)
4. Gerard C, Rollins BJ. Chemokines and disease. Nature Immunol 2001; 2: 108-15. (Pubitemid 33707927)
5. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-21. (Pubitemid 43209108)
6. Mabuchi T, Chang TW, Quinter S, et al. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci 2012; 65: 4-11.
7. Sokołowska-Wojdyło M, Roszkiewicz J. Role of the chemokines and their receptors in cutenaous T cell lymphomas [Polish]. Przegl Dermatol 2004; 91: 509-15. (Pubitemid 40193745)
8. Mazur G, Jaskuła E, Kryczek I. Role of chemokines in neoplasic diseases [Polish]. Adv Clin Exp Med 2004; 13: 315-25.
9. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-7. (Pubitemid 30398626)
10. Zlotnik A, Morales J, Hedrick JA. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 1999; 19: 1-47. (Pubitemid 29062100)
11. Nedoszytko B, Roszkiewicz J. The role of the subpopulations of dendritic cells in psoriasis [Polish]. Postep Derm Alergol 2007; 24: 263-70.
12. Shaw FL, Kimber I, Begum R, et al. No impairment of monocyte-derived Langerhans cell phenotype or function in early-onset psoriasis. Clin Exp Dermatol 2012; 37: 40-7.
13. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 Suppl. 2: ii30-6. (Pubitemid 40288517)
14. Krueger JG, Ellis CN. Psoriasis - recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005; 53 (1 Suppl. 1): S94-100.
15. Nedoszytko B. The role of subpopulations of lymphocytes in psoriasis [Polish]. Postep Derm Alergol 2008; 25: 20-33.
16. Nomura I, Gao B, Boguniewicz M, et al. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003; 112: 1195-202. (Pubitemid 37550015)
17. Zhou X, Krueger JG, Kao MC, et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 2003; 13: 69-78. (Pubitemid 37129170)
18. Raychaudhuri SP, Jiang WY, Farber EM. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 2001; 144: 1105-13. (Pubitemid 34204198)
19. Aung G, Niyonsaba F, Ushio H, et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology 2011; 132: 527-39.
20. Homey B, Alenius H, Müller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-65. (Pubitemid 34155127)
21. Homey B, Wang W, Soto H, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 2000; 164: 3465-70. (Pubitemid 30169794)
22. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A 1999; 96: 14470-5. (Pubitemid 30000674)
23. Plant D, Young HS, Watson R, et al. The CX3CL1-CX3CR1 system and psoriasis. Exp Dermatol 2006; 15: 900-3. (Pubitemid 44473329)
24. Gottlieb AB, Masud S, Ramamurthi R, et al. Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris. J Am Acad Dermatol 2003; 48: 68-75. (Pubitemid 36091536)
25. Kinney T, Rawlins M, Kozarek R, et al. Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions. Am J Gastroenterol 2003; 98: 608-12. (Pubitemid 36348533)
26. Rau R. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis 2002; 61 Suppl. 2: ii70-3. (Pubitemid 35221720)
27. Reiss Y, Proudfoot AE, Power CA, et al. CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte traficking to inflamed skin. J Exp Med 2001; 194: 1541-7. (Pubitemid 33081528)
28. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 19: 776-80. (Pubitemid 29399540)
29. Rottman JB, Smith TL, Ganley KG, et al. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alpha Ebeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001; 81: 335-47. (Pubitemid 32245066)
30. Wells TN, Power CA, Shaw JP, et al. Chemokine blockers: therapeutics in the making? Trends Pharmacol Sci 2006; 27: 41-7.
31. Toichi E, Torres G, McCormick TS, et al. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 2006; 177: 4917-26. (Pubitemid 44469828)
32. Homey B, Dieu-Nosjean MC, Wiesenborn A, et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000; 164: 6621-32. (Pubitemid 30408849)
33. Dieu-Nosjean MC, Massacrier C, Homey B, et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000; 192: 705-18.
34. Koelink PJ, Overbeek SA, Braber S, et al. Targeting chemokine receptors in chronic inflammatory diseases: an extensive review. Pharmacol Ther 2012; 133: 1-18.
35. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-60. (Pubitemid 36092023)
36. Trzeciak M, Sokołowska-Wojdyło M, Barańska-Rybak W, et al. Interleukin 18 - a pleiotropic cytokine involved in the Th1 and Th2 immunological response. Postep Derm Alergol 2011; 28: 309-12.
37. Siniewicz-Luzeńczyk K, Stańczyk-Przyłuska A, Zeman K. Correlation between serum interleukin 31 level and the severity of disease in children with atopic dermatitis. Postep Derm Alergol 2013; 30: 282-5.
38. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-60. Erratum in: Nat Immunol 2005; 6: 114. (Pubitemid 39023308)
39. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-80. (Pubitemid 36875617)
40. Pivarcsi A, Homey B. Chemokine network in atopic dermatitis: traffic signals of disease. Curr. Allergy Asthma Rep 2005; 5: 284-90. (Pubitemid 41149708)
41. Homey B, Steinhof M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006; 118: 178-89. (Pubitemid 43946487)
42. Narbutt J, Lesiak A, Sysa-Jedrzejowska A, et al. The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm 2009; 2009: 269541.
43. Lange M, Niedoszytko M, Nedoszytko B, et al. Aethiopathogenesis of mastocytosis: current options [Polish]. Postep Derm Alergol 2009; 26: 142-5.
44. Starska K, Brzezińska-Błaszczyk E. The role of stromal mast cells in the modification of CD4+CD25+Foxp3 regulatory T cells, Th17 lymphocytes and cytotoxic lymphocytes Tc1 in the development and progression of tumor [Polish]. Post Hig Med Dośw 2010; 64: 408-16.
45. Theoharides TC, Alysandratos KD, Angelidou A, et al. Mast cells and inflammation. Biochim Biophys Acta 2012; 1822: 21-33.